DECIPHERA PHARMACEUTICALS, LLC
Patent Owner
Stats
- 21 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 27, 2017 most recent publication
Details
- 21 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,046 Total Citation Count
- Dec 24, 2003 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0209,428 METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCERAug 31, 16Jul 27, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9457019 Methods for inhibiting tie-2 kinase useful in the treatment of cancerNov 07, 14Oct 04, 16[A61K, C07D, C07K]
9387202 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesNov 20, 14Jul 12, 16[A61K, C07D]
9382228 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Jul 05, 16[C07D]
9309224 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Apr 12, 16[C07D]
9193719 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Nov 24, 15[A61K, C07D]
9181223 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Nov 10, 15[A61K, C07D]
9133183 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Sep 15, 15[A61K, C07D]
9012635 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Apr 21, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0101,090 INHIBITION OF TRK KINASE MEDIATED TUMOR GROWTH AND DISEASE PROGRESSIONAbandonedOct 14, 15Apr 14, 16[A61K]
2015/0320,759 DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASESAbandonedDec 04, 14Nov 12, 15[A61K]
2015/0218,130 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedJan 22, 15Aug 06, 15[C07D]
2014/0194,405 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedDec 20, 13Jul 10, 14[C07D]
8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activitiesExpiredAug 21, 12Jul 16, 13[A01N, C07D]
2012/0289,540 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASESAbandonedApr 12, 12Nov 15, 12[A61K, A61P]
2012/0252,849 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedMay 24, 12Oct 04, 12[A61K, C07D, A61P]
2012/0225,057 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedSep 08, 11Sep 06, 12[A61K, C12N, A61P]
8143293 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseasesExpiredApr 18, 08Mar 27, 12[A61K, C07D]
2012/0058,985 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedApr 29, 11Mar 08, 12[A61K, C07D, A61P]
2011/0189,167 Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative DiseasesAbandonedAug 04, 10Aug 04, 11[A61K, A61P]
7897762 Kinase inhibitors useful for the treatment of proliferative diseasesExpiredSep 12, 07Mar 01, 11[A61K, C07D]
2008/0269,254 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedApr 18, 08Oct 30, 08[A61K, C07D, A61P]
2008/0269,267 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedApr 18, 08Oct 30, 08[A61K, C07D, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
